Point72 Asset Management, L.P.
Position in FHTX — Foghorn Therapeutics Inc.
CIK 1603466
STAMFORD, CT
Position in FHTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$132,147
-$202,480 QoQ
Shares Held
27,646
-55.4% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in FHTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $132,147 | 27,646 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $334,627 | 61,968 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,814,351 | 371,033 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,142,979 | 668,719 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,282,042 | 625,217 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $2,996,071 | 634,761 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,721,225 | 399,702 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,338,185 | 406,641 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $2,934,745 | 437,369 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,483,000 | 540,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,424,275 | 284,855 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,965,251 | 279,155 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $210,540 | 33,000 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,334,188 | 388,600 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,113,600 | 376,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $79,196 | 5,200 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,770,004 | 383,472 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $1,439,256 | 109,200 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||